JamesChappellMD

Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine

Are you Dr. Chappell?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. James Chappell, MD is a board certified pathologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee. He is affiliated with Vanderbilt University Medical Center and is an Assistant Professor at Microbiology and Immunology.

Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Vanderbilt University School of MedicineClass of 2001

PubMed

707 citations
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Timothy P. Sheahan, Amy C. Sims, Shuntai Zhou, Rachel L. Graham, Andrea J. Pruijssers
Science Translational Medicine. 2020-04-29
2155 citations
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael, Paul C. Roberts, Mamodikoe Makhene
The New England Journal of Medicine. 2020-07-14
26 citations
Characteristics of GII.4 Norovirus Versus Other Genotypes in Sporadic Pediatric Infections in Davidson County, Tennessee, USA.
Zaid Haddadin, Einas Batarseh, Lubna Hamdan, Laura S Stewart, Bhinnata Piya
Clinical Infectious Diseases. 2021-10-05

Early RSV Infection Linked to Significantly Increased Risk of Asthma in Children, Study Finds – ScienceDailyApril 25th, 2023
RSV Infection in the First Year of Life Associated with Increased Risk of Childhood AsthmaApril 24th, 2023
Tennessee Family, Hospital Celebrate as Last COVID-19 Patient Is Released After 53-Day FightMay 13th, 2020